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LOSS AVERSION IN COCAINE USERS:  
INFLUENCE OF RISK AND COMMODITY TYPE 
 
 
Numerous studies in behavioral economics have demonstrated that individuals are 
more sensitive to the prospect of a loss than a gain (i.e., loss aversion). Although loss 
aversion has been well described in healthy populations, little research exists in 
individuals with substance use disorders. The purpose of this study was to 
comprehensively evaluate loss aversion in cocaine users. Participants completed 
measures designed to assess loss aversion for drug and non-drug commodities under 
varying risk conditions. Cocaine demand was determined using a cocaine purchase 
task. Cocaine users showed a loss aversion score that was consistent across 
commodity and risk conditions. Compared to the normative loss aversion coefficient 
value (i.e., λ = 2) a large effect size decrease in loss aversion was observed in cocaine 
users. Hypothetical demand for cocaine was well explained by demand models. More 
intense and inelastic cocaine demand was also associated with greater loss aversion for 
cocaine. These data represent the first systematic study on loss aversion in cocaine 
using populations and indicate that reduced loss aversion is associated with cocaine 
use. Future studies should explore potential behavioral and neurobiological mechanisms 
to determine the benefit of loss aversion for treatment and intervention development 
efforts. 
 
KEYWORDS: Behavioral Economics; Demand; Drug; Gamble; Prospect Theory 
 
 
 
 
 
Justin Charles Strickland   
 
September 14, 2016      
 
 
  
LOSS AVERSION IN COCAINE USERS:  
INFLUENCE OF RISK AND COMMODITY TYPE 
By  
Justin Charles Strickland 
Dr. William Stoops 
Director of Thesis 
Dr. Mark Fillmore 
        Director of Graduate Studies 
September 14, 2016  
iii 
ACKNOWLEDGEMENTS 
I would like to express my deepest gratitude to my advisor, Dr. William Stoops, for 
his guidance when preparing this thesis and for his constant source of mentorship, 
encouragement, and inspiration. I would also like to thank Drs. Craig Rush and Joshua 
Lile for serving as an invaluable resource for my personal and professional development. 
I thank my committee members, Drs. William Stoops, Craig Rush, and Joshua 
Beckmann, for their time and thoughtful insights into this and other research projects. 
The Laboratory of the Human Behavioral Pharmacology staff continues to provide expert 
assistance and deserves much appreciation for this critical role. Finally, my gratitude 
goes out to my friends and family for their unwavering support. This research was 
supported by: National Institute on Drug Abuse Grant R21DA035376 [WWS] and 
National Science Foundation Grant 1247392 [JCS]. 
iv 
 
TABLE OF CONTENTS 
 
Acknowledgements .......................................................................................................... iii 
 
List of Tables .................................................................................................................... .v 
 
List of Figures................................................................................................................... vi 
 
Chapter One: Introduction ................................................................................................1 
Prospect Theory and Loss Aversion.....................................................................3 
Measures of Loss Aversion ..................................................................................5 
Loss Aversion in Clinical Populations ............................................................... …8 
Loss Aversion in Substance Using Populations ...................................................9 
Implications of Loss Aversion for Substance Use Disorders .............................12 
Summary and Purpose ................................................................................... …14 
 
Chapter Two: Methods....................................................................................................16 
Participants .........................................................................................................16 
General Procedure..............................................................................................17 
Payment Schedule .......................................................................................... …17 
Behavioral Measures and Task Analyses ..........................................................18 
Valuation Task: Loss Aversion Under Certainty.....................................18 
Mixed Gambles Task: Loss Aversion Under Risk .............................. …19 
Risk Aversion Task .................................................................................20 
Cocaine Purchase Task...................................................................... …20 
Data Analysis ......................................................................................................21 
Primary Outcomes: Loss Aversion by Risk and Commodity Condition .21 
Secondary Outcomes: Individual Differences in Loss Aversion ........ …23 
Power Analysis....................................................................................................23 
 
Chapter Three: Results...................................................................................................26 
Valuation Task Performance ..............................................................................26 
Mixed Gambles Task Performance ....................................................................26 
Loss Aversion by Risk and Commodity Condition ......................................... …27 
Individual Differences in Loss Aversion..............................................................28 
Cocaine Purchase Task......................................................................................28 
 
Chapter Four: Discussion ...............................................................................................39 
 
References ......................................................................................................................52 
 
Vita ..................................................................................................................................58 
 
 
 
v 
 
LIST OF TABLES 
 
Table 2.1, Participant Demographics and Drug Use Variables .....................................24 
Table 2.2, Timeline for Experimental Procedures ..........................................................25 
Table 3.1, Loss Aversion Scores for Valuation Tasks ...................................................30 
Table 3.2, Loss Aversion Scores for Mixed Gambles Tasks .........................................31 
Table 3.3, Semi-Partial Correlations Between Loss Aversion, Demographics, and Drug 
Use........................................................................................................................32 
Table 3.4, Primary Outcomes on the Cocaine Purchase Task......................................33 
Table 3.5, Semi-Partial Correlations Between Cocaine Demand and Loss Aversion 
Outcomes .............................................................................................................34 
Table 3.6, Spearman Correlations Between Demand Outcomes, Demographics, and 
Drug Use...............................................................................................................35 
 
 
vi 
 
LIST OF FIGURES 
 
Figure 3.1, Loss aversion coefficients for valuation (black bars) and mixed gambles 
(white bars) tasks .................................................................................................36 
Figure 3.2, Individual participant data from valuation (circles) and mixed gambles 
(squares) tasks. ....................................................................................................37 
Figure 3.3, Economic demand for cocaine in active cocaine users (n = 37) .................38 
 
 
 
  
1 
Chapter 1: Introduction 
Substance use disorders present a persistent public health concern, with the annual 
economic impact of illicit drug use estimated at $193 billion in the United States (United 
States Department of Justice, 2011). The most recent National Survey on Drug Use and 
Health (NSDUH) indicates that nearly 1.5 million persons aged 12 or over were current 
cocaine users and over half of those individuals met diagnostic criteria for a cocaine use 
disorder (Center for Behavioral Health Statistics, 2015). Other sources indicate that the 
NSDUH may underestimate the prevalence of active cocaine use, and that as many as 
3.9 million individuals use cocaine four or more times per month (Caulkins, Kilmer, 
Reuter, & Midgette, 2014). Cocaine use poses a particularly salient concern due to the 
relative lack of effective behavioral and pharmacological treatments for those seeking 
abstinence. Despite sustained efforts at identifying behavioral interventions and 
pharmacotherapies for cocaine use disorder, few effective treatments exist, and those 
that do suffer from selective effects, low retention, and high relapse rates (Dutra et al., 
2008; Stoops & Rush, 2013). 
Many of the diagnostic criteria for cocaine and other substance use disorders are 
defined by behaviors relevant to choice and decision-making. In the most recent edition 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) cocaine use 
disorder is diagnosed based on criteria including: an individual’s use of more cocaine 
than intended; unsuccessful efforts to control cocaine use; spending a large amount of 
time finding, using, or recovering from the effects of cocaine; using cocaine to the 
exclusion of other activities; continued use of cocaine despite problems caused by use; 
and use of cocaine in dangerous situations (American Psychiatric Association, 2013). 
Understanding how maladaptive patterns of choice develop and persist in substance use 
disorders is critical to identifying mechanisms of disease etiology and advancing 
intervention design. 
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Behavioral economics is the field of economics that characterizes choice and 
decision-making under conditions of constraint and attempts to explain departures from 
classic economic theory and decisions based on expected utility. Behavioral economic 
theorists posit that suboptimal behavior is a consequence of systematic choice biases 
that depart from traditional economic decisions (i.e., expected utility decisions). The 
recent application of behavioral economic principles to substance use research has 
resulted in exciting advances in both theoretical and empirical domains (Chivers & 
Higgins, 2012). For example, research on delay discounting has improved the field’s 
understanding of the etiology and treatment of substance use disorders. Delay or 
temporal discounting refers to the systematic reduction in the value of reinforcers as a 
function of delay to reinforcer delivery (Rachlin & Green, 1972). Numerous studies have 
demonstrated excessive discounting of delayed reinforcers in substance using 
populations, and the knowledge of this systematic bias has helped guide recent 
intervention efforts (e.g., as a putative moderator of treatment efficacy) (Bickel, 
Jarmolowicz, Mueller, Koffarnus, & Gatchalian, 2012; Washio et al., 2011). Exploration 
of other, understudied mechanisms of disordered choice could also result in significant 
research gains. 
Loss aversion is a choice bias that has received a great deal of attention in the 
behavioral economic literature (Novemsky & Kahneman, 2005). Numerous studies have 
demonstrated that, all things being equal, losses tend to have a greater impact on 
behavior than gains (Kahneman & Tversky, 1979; Tversky & Kahneman, 1991, 1992). 
For example, an individual receiving a $20 parking fine will report  a greater magnitude 
impact on behavior than an individual winning a $20 bet. This idea that losses loom 
larger than gains is used to explain a range of behavioral phenomena, such as the 
endowment effect (i.e., that individuals will sell a good for on average twice as much as 
they are willing to pay for the same good) (Rick, 2011). Despite the prevalence of 
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research exploring loss aversion in traditional economic contexts, little research exists 
that focuses on clinical populations. Even less attention has been paid to understanding 
loss aversion in substance using populations. The results of a PubMed search using the 
keywords “loss aversion” AND “drug” reveals only 17 papers, six of which are literature 
reviews. Investigating loss aversion in active substance users may provide critical insight 
into the etiology of substance use disorders and treatments targeting the suboptimal 
choices characteristic of drug use.  
Prospect Theory and Loss Aversion 
Prospect theory is a seminal model in behavioral economics used to explain choice 
in situations of risk, loss, and uncertainty (Kahneman & Tversky, 1979; Tversky & 
Kahneman, 1992). Central to prospect theory is the notion that behavioral preference is 
not determined by the final outcome of a choice, but instead, by the change relative to a 
reference point. In this way, it is not that a bank account might have changed by $50; it 
is whether this change was a gain or a loss that determines the relative impact. Value, 
then, is not an objective constant and is influenced by the relative reference point of a 
decision and its consequence.  
A key phenomenon explained by prospect theory is loss aversion. As described 
above, all things being equal, people are more sensitive to the prospect of losing a 
commodity than the prospect of gaining an equally valued commodity. Prospect theory 
predicts that receiving a $500 raise would produce a smaller magnitude positive impact 
than the negative impact of a $500 pay cut. Whereas when an employee that receives a 
raise might feel pleased and enthusiastic, if she were to receive a cut in pay, she might 
be deeply outraged or saddened. Although in both instances the objective value of  the 
change is equal, the reference point differs. Thus, at the broadest level, prospect theory 
and loss aversion suggest that the framing of an outcome as a loss or gain is a critical 
determinant of behavior, choice, and affective impact. 
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Mathematical models and behavioral measures of loss aversion are often used to 
quantify the relative impact of losses as compared to gains. The ratio comparing the 
relative value of avoiding losses to the pursuit of gains is described by the loss aversion 
coefficient, lambda (λ). Numerous studies have demonstrated that in the general 
population λ is approximately equal to 2 (Novemsky & Kahneman, 2005). This value 
suggests a 2:1 ratio of loss to gain, or that the impact of a loss is approximately twice 
that of an equivalent gain. This value also indicates that a gain must be twice the value 
of a loss to be of equal utility. Returning to the example of the disgruntled employee, 
only if her raise were $1000 would it be subjectively equal to a $500 cut in pay. 
Loss aversion occurs under both conditions of certainty (i.e., riskless) and risk 
regarding the outcome of that choice. Riskless choice refers to situations of certain 
outcome, such as buying or selling a commodity for a pre-determined price (Tversky & 
Kahneman, 1991). Loss aversion in this context is the behavioral mechanism used to 
explain the endowment effect wherein an individual will request on average twice as 
much to sell a commodity as he or she is willing to pay for that same good (Novemsky & 
Kahneman, 2005). For example, an employee may want a chocolate bar and be willing 
to buy it from a vending machine for $1.00. But if that employee’s friend also wanted a 
chocolate bar and decided to buy it from her, loss aversion and the endowment effect 
would predict that she would request at least $2.00 to sell her chocolate bar. 
Risky choice occurs during decisions of probability or chance (e.g., when making a 
gamble). Loss aversion in this context denotes disfavor of gambles with possible losses. 
The commonly confused phenomenon of risk aversion refers to a more general aversion 
towards outcome variability, regardless of whether that outcome is a loss or a gain. 
Individuals are more likely to reject gambles of positive expected value if the potential for 
loss is up to half as much as the expected gain (Tom, Fox, Trepel, & Poldrack, 2007). 
For example, if the employee decided to make some cash on the side and started 
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betting on coin flips with her coworkers, it is unlikely that she would accept gamble if the 
consequence was “heads you win $10 and tails you lose $10.” Even if the payoffs were 
a $10 gain for heads and a $6 loss for tails, she would still be unlikely to accept the bet. 
Only when the possible gain was twice or more the possible loss would she likely accept 
(e.g., $10 win to $5 loss). 
Although choice under certainty and under risk may present as qualitatively different 
conditions, the quantitative expression of loss aversion is similar. Both risky and riskless 
conditions produce loss aversion and result in loss aversion coefficients of approximately 
2 (Novemsky & Kahneman, 2005; Tom et al., 2007). The similarity in these experimental 
outcomes is suggestive of a common behavioral mechanism underlying choice. 
However, few studies have examined the relationship among behavioral measures of 
loss aversion using within-subjects manipulations. Those studies that do exist suggest 
that loss aversion is consistent across conditions of certainty and risk (Gachter, 
Johnson, & Herrmann, 2007). Additional research that directly compares behavioral 
measures of loss aversion under certainty and risk is needed. 
Measures of Loss Aversion 
Loss aversion has received a great deal of attention in the behavioral economic 
literature, with numerous studies demonstrating a robust and reliable avoidance of 
losses relative to pursuit of gains under certain and risky conditions. A number of 
behavioral tasks have been developed that quantitatively measure loss aversion. Many 
of these tasks define loss aversion by using a standardized loss aversion coefficient (i.e., 
λ) allowing for comparisons across studies and populations. 
One of the most popular tasks used to examine loss aversion is the valuation task 
(Kahneman, Knetsch, & Thaler, 1990). The valuation task is a measure of loss aversion 
under certain conditions. In the original version of this task, participants were randomly 
divided into a “buy” or “sell” group. Participants in the “buy” group were shown a 
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commodity (i.e., a coffee mug) and asked the maximum amount of money they were 
willing to spend to buy the mug. Participants in the “sell” group were given the same 
commodity and asked the minimum amount of money they were willing to sell the mug 
for. The ratio of sell to buy (or “Willingness-to-Accept to Wiliness-to-Purchase”; 
WTA:WTP) provides a behavioral index of loss aversion. 
In one of the earliest studies, students from a business statistics class were 
randomly selected to be buyers or sellers of a coffee mug (Kahneman et al., 1990). 
Participants were allowed to choose to buy (or sell) at prices ranging from $0.00 to $9.50 
in $0.50 intervals. Sellers in that study requested nearly double the median price 
compared to buyers, concordant with predictions from prospect theory (medians = $5.75 
to $2.21; λ = 2.6). Since then, numerous studies have replicated this finding across 
commodities (e.g., pens, orange juice, etc.) and shown sensitivity to experimental 
manipulations such as time (e.g., length of ownership) and likelihood of trading the 
commodity in the future (see reviews by Morewedge & Giblin 2015; Novemsky & 
Kahneman, 2005). For example, a short expected length of ownership attenuates the 
WTA to WTP gap, whereas decreasing the opportunity to trade or sell the good at a later 
date enhances this gap. 
More varied behavioral measures of loss aversion exist for conditions of risky choice. 
One popular method for examining deficits in decision-making is the Iowa Gambling 
Task (IGT; Bechara, Damasio, Damasio, & Anderson, 1994; Bechara et al., 2001). In the 
IGT, participants make a series of choices from four decks of cards in which every 
choice results in a gain that is sometimes coupled with a simultaneous loss. Selections 
from two disadvantageous decks results in a net loss, whereas selections from two 
advantageous decks results in a net gain. In the original demonstrations of the IGT, 
participants with ventromedial prefrontal cortex damage showed poor performance 
attributed to an indifference for long-term consequences (Bechara, Damasio, Tranel, & 
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Damasio, 1997). A number of investigators have used the IGT in the context of loss 
aversion and attributed poor performance to deficits in the anticipation of long-term 
consequences for disadvantageous decks, hypersensitivity to rewards, and/or 
hyposensitivity to losses (e.g., Ahn et al., 2014). 
A distinct limitation of the IGT is the difficulty in distinguishing the relative contribution 
of loss aversion from the inability to learn from feedback. One solution is the use of 
mathematical modeling to decompose IGT behavioral performance into distinct 
behavioral constructs. For example, the Prospect Valence Learning (PVL) model divides 
performance into four constructs: 1) loss aversion (λ), 2) reward sensitivity (α), 3) 
recency (A), and 4) consistency (c) (Ahn, Busemeyer, Wagenmakers, & Stout, 2008; 
Fridberg et al., 2010; Vassileva et al., 2013). Alternatively, the Expectancy Valence 
(EVL) model divides performance into three constructs: 1) motivation (responsiveness to 
risk), 2) learning/memory (updating expectancies about the value of risky alternatives), 
and 3) sensitivity/consistency (trial-by-trial matching with expected outcomes) 
(Busemeyer & Stout, 2002; Lane, Yechiam, & Busemeyer, 2006; Stout, Busemeyer, Lin, 
Grant, & Bonson, 2004). The use of mathematical modeling has provided evidence of 
differential loss aversion in various clinical populations (Ahn et al., 2014; Busemeyer & 
Stout, 2002; Fridberg et al., 2010; see below for more detail). 
A popular alternative to the IGT, particularly in the economic literature, is the mixed 
gambles task. Participants in this task are asked to accept or reject gambles of varying 
probabilities and varying loss-to-gain magnitudes. Although variations in the task may 
alter the specific probabilities, magnitudes, and choice types (e.g., Gamble #1 versus 
Gamble #2, Gamble versus No Gamble), these measures have consistently 
demonstrated loss aversion in the general population.  In one of the most popular 
versions of the mixed gambles task, participants decide whether to accept or reject 
50/50 bets (i.e., coin flips) with varying magnitude gains and losses (Tom et al., 2007). 
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Individuals on this task are more likely to reject gambles in which the possible gain is 
less than double the possible loss, which is consistent with other measures of loss 
aversion. For example, a wager with a possible gain of $50 is typically rejected if the 
possible loss is $25 or more. A major benefit of the mixed gambles task is that skill and 
prior learning do not mediate performance, unlike the IGT. Because gamble results are 
not displayed throughout the task (i.e., the participant is blind to gamble outcomes), 
feedback-based responding also does not influence behavior. 
Loss Aversion in Clinical Populations 
Few studies have examined loss aversion in clinical populations and even fewer 
have examined individuals with substance use disorders. Attenuated loss aversion has 
been observed in individuals with schizophrenia under both riskless and risky conditions 
(Brown et al., 2013; Tremeau et al., 2008). Patients with schizophrenia in one of these 
studies failed to show loss aversion in a valuation task and demonstrated higher 
requested prices as buyers than as sellers (λ = 0.87; Tremeau et al., 2008). Loss 
aversion coefficients in that study correlated with duration of illness, but not measures of 
current psychopathology. This finding suggests that altered loss aversion may be a 
consequence of sustained behavioral and/or biological changes over disease course 
rather than a function of acute symptomology. Similarly, under conditions of risk, 
individuals with schizophrenia show deviations from normal decision-making and an 
impaired assessment of expected value (Brown et al. 2013). In contrast to these 
findings, patients with depression show enhanced loss aversion relative to control 
groups (Chandrasekhar Pammi et al. 2015). Performance on a mixed gambles task in 
that study indicated higher loss aversion coefficients in depressed patients. Furthermore, 
activity in regions of the midbrain and ventral tegmental area were associated with these 
enhanced λ values. These findings are notable given that a previous neuroimaging study 
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in healthy controls also implicated regions of the mesolimbic and mesocortical dopamine 
systems in loss aversion (Tom et al., 2007). 
A series of studies has examined loss aversion in problem gamblers and revealed 
mixed findings. One of these studies found attenuated loss aversion in gamblers in 
outpatient treatment that performed the IGT and a mixed gambles task (Lorains et al. 
2014). In contrast, another study found that problem gamblers undergoing treatment 
showed enhanced loss aversion that corresponded with the stage of treatment (i.e., 
higher loss aversion in later-stage treatment; Giorgetta et al. 2014). In another study, 
poorer performance on a mixed gambles task and the IGT was observed in non-
treatment seeking gamblers (Brevers et al. 2012). Although that study did not directly 
compute a loss aversion coefficient, performance was consistent with attenuated loss 
aversion. Taken together, these findings support the notion that loss aversion may relate 
to and be altered by treatment status in problem gamblers. 
Loss Aversion in Substance Using Populations 
Little research has evaluated loss aversion in substance using populations and the 
research that exists has focused on risky loss aversion. A majority of these studies have 
used the IGT in combination with various computational models in order to isolate 
behavioral constructs of loss aversion. Few studies exist in substance using populations 
utilizing mixed gambles tasks, and none have compared loss aversion under certainty 
and risk by using a within-subjects design. 
The acute effects of drugs on loss aversion have been examined in two studies 
(George, Rogers, & Duka, 2005; Lane et al., 2006). In the first of these studies, 
participants were administered alcohol (0.6 g/kg) or placebo and asked to perform a 
mixed gambles task (George et al., 2005). Gambles in this task varied in loss and gain 
magnitude as well as in probability. Acute alcohol produced an impaired assessment of 
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gain magnitude and probability. Importantly, no differences in reaction time were 
observed suggesting that these effects were not due to general motor impairment.  
The second of these studies was a retrospective analysis of data from studies 
evaluating the acute effects of alcohol, cannabis, and alprazolam (Lane et al., 2006). All 
included studies used an experimenter-designed risk-taking task in which participants 
chose between a non-risky, low payoff and risky, high payoff option. These data were 
examined using the EVL model providing measures of reward responsiveness, learning, 
and outcomes sensitivity. Acute alcohol (0.8 g/kg) produced a heightened sensitivity to 
rewards and/or decreased sensitivity to losses, but did not change learning from 
previous outcomes and response sensitivity. In contrast, acute cannabis (3.58%) 
impaired learning and sensitivity to outcomes, but produced no changes in valence 
sensitivity. Finally, alprazolam (2 mg) administration only impaired learning from 
previous outcomes and did not affect valence or response sensitivity. Important to note 
is that these acute drug effect studies were conducted in social drinkers and student 
populations. It remains unknown if the reported acute effects of drugs on loss aversion 
would extend to individuals with substance use disorders. 
One study examined abstinent amphetamine- and heroin-dependent individuals 
performing the IGT whose performance was analyzed using a variety of computational 
models (Ahn et al., 2014). These participants were in extended abstinence, with at least 
a three-month period since the last reported drug use. Abstinent heroin users in that 
study showed attenuated loss aversion relative to healthy controls. Amphetamine-
dependent individuals, in contrast, showed increased reward sensitivity, but not 
attenuated loss aversion relative to controls. These findings indicate that particular 
decision-making deficits may remain during abstinence, and that these deficits may differ 
as a function of abused substance. 
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One study has examined loss aversion in chronic cannabis users (Fridberg et al., 
2010). These investigators found that the PVL model provided the best fit to the 
experimental outcomes and that attenuated loss aversion on the IGT was observed in 
cannabis users relative to matched controls. These findings indicated that cannabis 
users treated loss as constant and of relatively minor impact regardless of loss 
magnitude. Additionally, decisions made by cannabis users showed inconsistency with 
respect to expected outcomes suggesting an impaired computation of expected value.  
A number of studies have demonstrated impaired performance by active cocaine 
users on the IGT (e.g., Balconi, Finocchiaro, & Campanella, 2014; Hulka et al., 2014; 
Stout et al., 2004). In one such study, male cocaine users completed the IGT and 
parameters from computational models were compared to matched controls (Stout et al., 
2004). These individuals showed an impaired risk responsiveness resulting in attenuated 
sensitivity to losses and/or an enhanced sensitivity to gains. Furthermore, cocaine users 
showed impaired sensitivity to expected value and greater randomness in choice (i.e., 
non-concordant with expected value). Although no direct measures of loss aversion 
were computed, these findings are suggestive of an attenuation of loss aversion in 
cocaine-using populations. 
Another study examined women enrolled in a longitudinal study on HIV (Vassileva et 
al., 2013). A subset of these women reported a history of illicit drug use, including heroin 
and/or cocaine use. In that study, participants completed the IGT and parameter values 
were compared using the PVL computational model. Drug use was associated with 
decreases in loss aversion and impaired learning from feedback and HIV+ status with 
reductions in loss aversion. However, only 14% of the women in the drug-use condition 
reported current cocaine use, making inferences about the specific role of active cocaine 
use on loss aversion difficult. 
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In contrast to these other studies, data obtained in HIV-positive cocaine users 
suggests enhanced loss aversion (Meade, Young, Mullette-Gillman, Huettel, & Towe, 
2014). Participants in that study performed a mixed gambles task and completed 
measures of substance use and sexual risk taking. Individuals with active cocaine use 
reported greater loss aversion than those that did not, and within this group, loss 
aversion was positively associated with sexual risk behavior and missing medication 
appointments. It is important to note that these data were presented at the 2014 annual 
meeting of the College on Problems of Drug Dependence and have not been published 
in a peer-reviewed format. It is also unclear if these results are a function of cocaine use, 
HIV status, or a unique combination of the two. Investigating the specific role of active 
cocaine use in expression of loss aversion will be crucial for clarifying these 
discrepancies. 
The reviewed literature suggests that drug use is related to deviations in expected 
value computation and loss aversion. These collective findings indicate that the use of 
drugs from multiple classes, including cannabis, opioids, and psychomotor stimulants, is 
associated with decreases in loss aversion. Additional research is needed, however, to 
clarify discrepancies observed in some studies (e.g., Meade et al. 2014) and to 
understand the cross-context consistency of loss aversion through the use of multi-
method, within-subjects techniques. 
Implications of Loss Aversion for Substance Use Disorders 
Loss aversion could play a role in the etiology and persistence of substance use 
behaviors. Maladaptive patterns of drug taking maintained by the inability to adequately 
assess losses and gains and a consequent over- or undervaluation of negative 
consequences (e.g., withdrawal, unemployment) would likely result in the enduring drug 
use phenotypes often observed in the clinical setting. Loss aversion may also relate to 
clinical status as observed in problem gamblers. If this is true, loss aversion could 
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provide a behavioral marker for substance use diagnosis and assessment. 
Demonstrating that loss aversion correlates with the clinical expression of cocaine use 
would be essential for demonstrating a causal role in the clinical condition, rather than as 
an epiphenomenon of the disorder. 
Examining loss aversion in substance using populations may also be important for 
intervention design. In particular, loss aversion has a substantive relationship to 
outcomes in contingency management (CM). Differences in loss aversion could 
potentially affect the subjective impact of monetary incentives when framed as gains as 
opposed to losses (e.g., “contract-base” CM). Evidence from smoking CM interventions 
suggests that loss-framed incentives differentially motivate abstinence initiation, whereas 
gain-framed incentives help to sustain abstinence (Romanowich & Lamb, 2013). 
Assessing sensitivity to loss aversion could provide a putative moderator of CM efficacy 
and contribute to patient-level tailoring of CM design. 
It is unknown how loss aversion might relate to drug-taking behaviors. The recent 
development of self-reported purchase tasks to measure economic demand for drugs 
and other commodities provides a simple method to measure this relationship (e.g., 
Amlung, McCarty, Morris, Tsai, & McCarthy, 2015; MacKillop et al., 2008; Murphy & 
MacKillop, 2006). Participants are asked on these tasks to report consumption of 
specific commodities (e.g., cocaine) across changes in price. Transformation of the 
price-level consumption into demand curves allows for the mathematical modeling of 
demand parameters, such as intensity (Q0; consumption at zero cost) and elasticity (α; a 
measure of the change in consumption with change in unit price). Additional parameters 
may also be generated from the raw demand curve (e.g., breakpoint or the point where 
consumption drops to zero). Demand curves, then, provide the benefit over traditional 
measures of drug reinforcement (e.g., response rate) of effectively and efficiently 
isolating several behavioral mechanisms of drug use.  
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A majority of research on drug purchase tasks has examined alcohol and nicotine 
consumption (e.g., Murphy, MacKillop, Skidmore, & Pederson, 2009; MacKillop et al., 
2008, 2012). Our laboratory has recently developed a cocaine purchase task modified 
from previous literature (Bruner & Johnson, 2014) and demonstrated reliable outcomes 
and correspondence between cocaine demand parameters and cocaine use variables 
(Stoops et al., 2016; Strickland, Lile, Rush, and Stoops, in press; Strickland, Reynolds, & 
Stoops, in press). The use of a cocaine purchase task in conjunction with measures of 
loss aversion will allow for the rapid and efficient study of the relationship between these 
behavioral economic outcomes.  
Summary and Purpose 
Loss aversion refers to the general tendency for losses to have a greater impact on 
behavior than equal magnitude gains. Behavioral economics suggests a number of 
contexts in which loss aversion is expressed, including under conditions of certainty and 
risk regarding the outcome of choice. Far less is known about loss aversion in substance 
using populations. The available literature suggests that clinically relevant drug use is 
associated with diminished loss aversion relative to normative populations. More 
information is necessary to clarify discrepant results, evaluate the relationship between 
loss aversion and behavioral mechanisms of drug use, and examine the cross-context 
consistency of loss aversion through the use of multi-method, within-subjects 
techniques. 
The primary purpose of this study was to examine loss aversion in active 
cocaine users. Loss aversion was evaluated using a multi-method test battery that 
varied in the level of risk present and the commodity available. Loss aversion under 
riskless contexts was assessed using a valuation task and loss aversion under risky 
contexts assessed using a mixed gambles task. Although previous research supports a 
correspondence between loss aversion under certainty and risk (Gachter et al., 2007), it 
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is unknown if this relationship holds in drug-using populations. The commodity available 
was manipulated in order to evaluate potential differences in loss aversion for drug (i.e., 
cocaine) and non-drug (e.g., money) outcomes. A risk aversion task was also included 
to determine the specific contribution of loss aversion over more general aversion to 
uncertain outcomes.  
It was hypothesized that loss aversion would deviate from normative values (i.e., λ = 
~2) in active cocaine users. Given the discrepancies reported in prior research, no 
directional hypothesis was made about this deviation. It was also expected that risky and 
riskless loss aversion would correlate in active cocaine users, concordant with the 
relationship observed in the general population. Finally, loss aversion was predicted to 
be greater for drug than for non-drug commodities. 
A secondary aim was to evaluate the relationship between loss aversion and 
behavioral mechanisms of drug use. A cocaine purchase task was used to isolate 
behavioral mechanisms of cocaine demand and determine the association between loss 
aversion and cocaine demand. Additional analyses were conducted to identify individual 
differences in loss aversion as a function of other cocaine use variables (e.g., monthly 
cocaine use) and demographics (e.g., age, sex). 
Cocaine demand was predicted to decrease as a function of price and be well 
explained by the exponentiated demand equation. It was also expected that intensity of 
demand would positively and elasticity of demand negatively correlate with cocaine use 
variables (e.g., frequency of current cocaine use, lifetime cocaine use), further validating 
the cocaine purchase task. Loss aversion coefficients were anticipated to correlate with 
intensity of demand and elasticity of demand, although a directional hypothesis was not 
made for reasons stated above. 
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Chapter 2: Methods 
Participants 
A total of 38 participants (22 male; 16 female) provided sober, written informed 
consent to participate in this within-subjects, outpatient study. All potential participants 
underwent a comprehensive screening process (Stoops, Lile, & Rush, 2010). The 
screening procedure included series of health, psychiatric, and drug use history 
questionnaires including: the Beck Depression Inventory, Brief Symptom Index, and 
assessments for ADHD, mental status, and drug and alcohol use disorders. Drug use 
histories (e.g., time since first use, frequency and quantity of current use, and times used 
over lifetime) were collected for amphetamines, barbiturates, benzodiazepines, 
cannabis, cocaine, hallucinogens, inhalants, and opioids. Standardized drug use 
questionnaires included the Drug Abuse Screening Test (DAST), Fagerström Test for 
Nicotine Dependence (FTND), and the Michigan Alcohol Screening Test (MAST). 
Participants also completed the impulsivity subscale of the Zuckerman-Kuhlman 
Personality Questionnaire (ZKPQ). Diagnostic criteria for Cocaine Abuse or Dependence 
were assessed using the computerized Structured Clinical Interview for DSM-IV (SCID), 
but presence of a cocaine use disorder was not an inclusion criterion to allow cocaine 
use behaviors to freely vary. Participants were excluded if they endorsed a history of 
serious physical disease, current centrally acting medication, or current or past histories 
of serious psychiatric disorder that would interfere with study participation. Participants 
with a history of a substance use disorder that was deemed to interfere with study 
completion (e.g., physiologic alcohol dependence) were also excluded. 
Participants were English-speaking, English-reading, and 18 years of age or older. 
The sample was generally male (58%) and African American (82%) with a high school or 
certification-equivalent education (e.g., GED). All participants reported recent cocaine 
use verified by a cocaine- or benzoylecgonine-positive urine sample. Most participants 
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reported an extensive history of cocaine use (interquartile range [IQR] = 16 to 26 years) 
and a majority met criteria for a cocaine use disorder (94.7%). Demographic and self-
reported drug use variables are presented in Table 2.1. 
Participants were told that the purpose of the study was to learn about how people 
make decisions. Other than this general explanation of purpose, participants were not 
given any information concerning what outcomes might be expected. The study was 
conducted in accordance with all relevant guidelines, including the Declaration of 
Helsinki, and approved by the Medical Institutional Review Board of the University of 
Kentucky. 
General Procedure 
This within-subjects, outpatient study consisted of one session and took 
approximately one to two hours for each participant to complete. The session took place 
during screening for other outpatient and inpatient protocols at the University of 
Kentucky Laboratory of Human Behavioral Pharmacology (LHBP). Participants that met 
the eligibility criteria above came to the LHBP, underwent a field sobriety test, and 
provided an expired air sample that was required to be negative for alcohol. Participants 
were also required to provide a urine specimen that was tested for recent use of 
amphetamine, benzodiazepines, barbiturates, cocaine, tetrahydrocannabinol (THC), and 
opioids. This specimen had to be negative for all substances except cocaine to 
participate in the experimental protocol that day. Sessions could proceed with a THC 
positive specimen, but the participant had to pass a standard field sobriety test to ensure 
they were not acutely intoxicated.  
Payment Schedule 
Participants were provided $30 for use in behavioral tasks and told that they could 
use this money for purchasing items and making gambles. They were also told that their 
compensation would vary depending on task performance, but that the total amount 
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earned would not be less than $0 (i.e., they would not owe the experimenters money). In 
actuality, all participants earned $10 for the mixed gambles and risk aversion tasks (see 
below) for a maximum compensation of $60 dependent on valuation task choice 
(valuation task commodities received + $20 to $60 task compensation). 
Behavioral Measures and Task Analyses 
Valuation Task: Loss Aversion Under Certainty. A valuation task was used to 
determine loss aversion under certainty (Gachter et al., 2007; Kahneman et al., 1990). In 
the “Willingness-to-Accept” (WTA) condition, participants were given a commodity (e.g., 
coffee mug) and told they could keep it. Participants were then asked to indicate the 
price(s) at which they would be willing to sell the commodity. Prices varied from $0.50 to 
$10.00 in $0.50 increments for non-drug commodities. The “Willingness-to-Purchase” 
(WTP) condition was identical except that participants were shown the commodity and 
told they had the opportunity to purchase it. Participants were then asked to indicate at 
each price whether they were prepared to buy the commodity. Although valuation tasks 
have typically used a coffee mug as the commodity, the current study also used 
headphones given that pilot testing indicated that participants considered headphones 
an ecological relevant commodity. Participants were told that one price point from the 
task would be randomly selected and the decision carried out (e.g., receipt of the good 
or money) to encourage active participation. A novel cocaine valuation task was also 
used to assess loss aversion for drug commodities. Participants were asked to make 
hypothetical decisions about purchasing or selling 1 g of cocaine for prices ranging from 
$10 to $200 in $10 increments. All other procedures were identical to the traditional 
valuation task.  
Headphone, mug, and cocaine valuation tasks were presented in a randomized 
order. Presentation order for the WTA and WTP conditions was also counterbalanced 
across participants with approximately 30 minutes between tasks to avoid carryover 
  
19 
effects. The primary outcome from the valuation task was the ratio of WTA/WTP that 
provides a standardized measure of loss aversion (i.e., λ). Previous research indicates 
normative values for λ of approximately 2, indicating that individuals will typically ask for 
twice the amount to sell than they will to purchase the same commodity (Kahneman et 
al., 1990; Novemsky & Kahneman, 2005).  
Mixed Gambles Task: Loss Aversion Under Risk. A mixed gambles task (i.e., coin 
flip task) was used to determine loss aversion under risk (Tom et al., 2007). Participants 
were asked to accept or reject gambles offering a 50/50 chance of winning or losing 
variable amounts of money. Gains ranged from $10 to $40 in increments of $2, whereas 
losses ranged from $5 to $20 in increments of $1. These ranges were selected to 
produce a range of gambles that could account for an approximate two-fold difference in 
sensitivity to loss versus gain (λ = 2) and to be consistent with previous uses of the task. 
All 256 possible combinations of gains and losses were presented in a randomized 
order. Participants were told to respond carefully because one trial would be chosen at 
random and compensation provided based on that trial. However, as indicated above, all 
participants were paid $10 for participation in the mixed gamble and risk aversion tasks. 
The primary outcome from this task was λ, calculated as λ = -βloss/βgain derived from the 
logistic regression of 1) gain magnitude and 2) loss magnitude on trial choice (i.e., 
accept versus reject as the criterion). Participants were excluded if the logistic 
regression model could not converge or when the validity of the model fit was in question 
(e.g., complete or quasi-complete separation). Nine participants were excluded from one 
or more mixed gambles analyses because their choices did not allow for generation of 
accurate λ terms using logistic regression (Money Task Only = 2; Cocaine Task Only = 
4; Both Tasks = 3). In general, this reflected a propensity to accept too many gambles 
(e.g., all gambles), such that generation of logistic regression coefficient terms was not 
accurate. 
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Risk Aversion Task. A risk aversion task was used to assess general aversion 
towards outcome variability (De Martino, Camerer, & Adolphs, 2010). Participants were 
presented with double or nothing gambles. The task consisted of 11 trials and included 
the following monetary values: $2, 5, 10, 15, 20, 25, 30, 35, 40, 45, and 50. Participants 
were told to respond carefully because one trial would be chosen at random and 
compensation provided based on that trial. However, as indicated above, all participants 
were paid $10 for participation in the mixed gamble and risk aversion tasks. The primary 
outcome from the risk aversion task was the number of gambles accepted. Previous 
studies of loss aversion have used this measure to account for general distaste for risk 
over a specific aversion to loss (De Martino et al., 2010). 
Cocaine Purchase Task. A cocaine purchase task was used to assess economic 
demand for cocaine (Stoops et al., 2016). Participants were asked to indicate the 
hypothetical number of cocaine “hits” (i.e., 0.1 g cocaine units) they would purchase at 
16 monetary increments ranging from $0.00 [free] to $1000 per 0.1 g. All choices were 
hypothetical and were not purchased or administered. Data from the cocaine purchase 
task were analyzed using nonlinear regression and the exponentiated demand equation 
(Koffarnus, Franck, Stein, & Bickel, 2015; Strickland et al., in press; Equation 1): 
Equation 1: 𝑄 = 𝑄0 ∗ 10
𝑘∗(𝑒(−𝛼∗𝑄0∗𝐶)−1)  
Where Q = consumption; Q0 = derived intensity of demand (consumption at zero price); 
k = a constant that denotes the range of consumption values in log10 units (set to 4 for all 
analyses); C = the price of the commodity; and α = derived essential value (a measure of 
elasticity of demand). Greater values of Q0 indicate greater consumption at 
unconstrained price (i.e., a theoretical price of zero). Greater values of α indicate a 
higher elasticity of demand or change in consumption with change in unit price. 
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Purchase task data have traditionally been modeled using the exponential demand 
equation (Hursh & Silberburg, 2008; Equation 2): 
Equation 2: log10 𝑄 = log10 𝑄0 + 𝑘 ∗ (𝑒
(−𝛼∗𝑄0∗𝐶) − 1)  
However, recent evidence indicates that the exponentiated model provides a superior fit 
because this model can incorporate zero consumption values without transformation 
(Koffarnus et al., 2015; Strickland et al., in press). Given the relative novelty of the 
exponentiated model, the exponential model was tested to verify the exponentiated 
model’s superior fit. Zeros were replaced with an arbitrary non-zero number (0.01) for 
the exponentiated model analysis, consistent with standard practice (Koffarnus et al., 
2015). Table 2.2 presents the timeline for all experimental tasks and procedures. 
Data Analysis 
Primary Outcomes: Loss Aversion as a Function of Risk and Commodity. 
Standardized loss aversion coefficients (λ) were calculated for individual tasks as 
described above. One-sample t-tests were used to determine if λ values differed from 
the population normative value of 2. This value was selected because it is the typical λ 
value observed in non-clinical (i.e., normative) populations (see Kahneman & Tversky, 
1979; Novemsky & Kahneman, 2005; Tversky & Kahneman, 1992). This value also lies 
within the range of values described by several meta-analyses on WTP/WTA disparities 
(Neumann & Böckenholt, 2014; Sayman & Öncüler, 2005; Tunçel & Hammitt, 2014). 
Loss aversion 95% confidence intervals were evaluated to determine the precision of the 
present estimate and the margin of difference from the prototypic value of 2. 
A follow-up analysis was conducted with valuation task data to determine if the 
within-subjects manipulation presented a potential confound (e.g., carryover responding 
from WTP to WTA or vice versa). This analysis closely resembles the methods used in 
traditional valuation task studies in which each participant only completes one task (i.e., 
a between-subject manipulation). Data from the first task each participant completed 
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were used and independent-samples t-tests conducted comparing WTA and WTP 
values between groups. Median values for WTP and WTA were also used in this follow-
up analysis to generate estimated λ values. Median values were used in this between-
subjects designs to account for potential distributional skew and/or outliers as described 
previously (see Kahneman et al., 1990). A secondary analysis of mixed gambles data 
was also conducted to determine the predicted probability of gamble acceptance at an 
expected value of zero, as well as the expected value at which the predicted probability 
of gamble acceptance was 50%. These values were determined using logistic 
regression with expected value as the predictor and choice as the criterion.   
A high proportion of participants (60.5%) indicated that the price range used for the 
headphone valuation task was too restrictive and that they would sell or purchase the 
headphones for more than $10.00. Given this potential methodological confound, only 
the mug commodity was used for the remainder of analyses. The influence of risk and 
commodity type on loss aversion was examined using a 2 x 2 ANOVA with Risk 
(Riskless versus Risky) and Commodity (Non-Drug versus Drug) as the within-subjects 
factors. Risk aversion and counterbalance order were included as covariates in 
additional models to evaluate the influence of these potential confounds on study 
outcomes. The effects of Risk and Commodity Type were also evaluated using linear 
mixed-effects models in the lme4 package for R statistical software (Bates, Maechler, 
Bolker, & Walker, 2015), with Risk, Commodity, and the Risk x Commodity interaction 
defined as fixed, within-subjects factors and participant defined as a random factor. An 
alternative approach of using difference scores (e.g., WTP – WTA) rather than ratios 
was also explored. The outcomes of these analyses were not qualitatively different than 
ratios, and therefore, for parsimony and comparison to the broader research literature, 
only ratio analyses are reported. The relationship between λ values from valuation and 
mixed-gambles tasks were analyzed using Spearman rank correlations. Non-parametric 
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Spearman rank correlations were used for to help control type I and type II error rate 
inflation due to non-normal variable distributions (Bishara & Hittner, 2012).  
Secondary Outcomes: Individual Differences in Loss Aversion. Cocaine 
purchase data were analyzed in GraphPad Prism 6.0f (GraphPad Software Inc.; La 
Jolla, CA), as described above. Additional parameters, including intensity (consumption 
at zero price), Omax (maximum amount of money allocated to cocaine purchase), Pmax 
(price at which Omax is achieved), and Breakpoint (first price at which consumption is 
zero) were computed graphically (e.g., Amlung et al., 2015; MacKillop et al., 2008; 
Murphy & MacKillop, 2006). All demand metrics were log-transformed to correct for a 
high degree of skew. The relationship between derived intensity (Q0) and reported 
consumption at zero price was used to evaluate model appropriateness. Multiple 
regression models including gain and loss coefficients (e.g., WTP, WTA) and λ values 
were used to evaluate the relationship between λ and purchase task and demographic 
outcomes. The incremental validity of adding λ to models including components of the 
ratio was determined and statistically significant increments in R2 interpreted using semi-
partial correlations. Spearman rank correlations were also used to determine if purchase 
task metrics were associated with other drug use (e.g., DAST, monthly cocaine use) and 
demographic (e.g., age, sex) variables. All ANOVAs and correlational analyses were 
conducted in SPSS Statistics 22 (IBM; Armonk, NY) with a type I error rate of 0.05. 
Power Analysis 
An a priori power analysis was conducted to determine the sample size needed to 
detect a medium effect size difference from 2 for λ (Cohen’s d = .50) using two-tailed 
tests and a type I error rate of .05. This power analysis indicated that 38 participants 
would be needed to detect this effect with 85% power. 
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Table 2.1 Participant Demographics and Drug Use Variables 
 
  Mean SD 
Age 45.7 5.8 
Females 16 (42%) 
 
Race 
  
Caucasian 7 (18%) 
 
African American 31 (82%) 
 
Years of Education 12.1 1.5 
Income $7155 $7479 
ZKPQ 1.4 1.7 
CPD 11.8 7.4 
FTND 3.8 2.3 
Alcoholic Drinks Per Week 14.6 17.0 
MAST 8.4 8.8 
DAST 10.2 5.6 
Cocaine Use 
  
Days Used Per Month 15.7 9.2 
Money Spent Per Month $659.5 $701.0 
Lifetime Uses 3562.6 2715.6 
Years Used 20.3 8.3 
Note. ZKPQ = Impulsivity Subscale of the Zuckerman-
Kuhlman Personality Questionnaire; CPD = cigarettes per day; 
FTND = Fagerström Test for Nicotine Dependence; MAST = 
Michigan Alcohol Screening Test; DAST = Drug Abuse 
Screening Test. 
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Table 2.2 Timeline for Experimental Procedures 
 
Time Experimental Activity 
0 h Arrival 
0 – 0.25 h Sobriety Test, Urine Screen, Pre-Session Paperwork/Informed Consent 
0.25 – 0.50 h Traditional and Cocaine Valuation Tasks 1 (WTA/WTP)* 
0.50 – 0.75 h Traditional Mixed Gambles Task 
0.75 – 1.00 h Break 
1.00 – 1.25 h Cocaine Mixed Gambles Task 
1.25 – 1.50 h 
Traditional and Cocaine Valuation Tasks 2 (WTA/WTP)* 
Risk Aversion and Cocaine Purchase Task 
1.50 h Participant Payment/Discharge 
 
*Presentation of Willingness-to-Accept (WTA)/Willingness-to-Purchase (WTP) conditions 
of valuation tasks counterbalanced across participants 
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Chapter 3: Results 
Valuation Task Performance 
Means and standard deviations for WTP, WTA, and λ values on the headphone, 
mug, and cocaine valuation tasks are presented in Table 3.1. Similar magnitude prices 
for selling (WTA) and buying (WTP) conditions were observed for all commodities, as 
indicated by an average λ of approximately 1 (Headphones = 1.04; Mug = 1.15; Cocaine 
= 1.14). One-sample t-tests showed that λ values for all commodities were significantly 
lower than a standard value of 2, t37 values > 6.95, p values < .001, d values > 1.13 (see 
Table 3.1). 
Follow-up analysis analogous to the methods used in traditional valuation task 
studies (i.e., using only data from the first task completed by each participant) supported 
the conclusions from the within-subjects comparisons. Specifically, independent-
samples t-tests did not reveal statistically significant differences in prices for selling and 
buying conditions for the three commodities, Headphones: t36 = 0.77, p = .45; Mug: t36 = 
0.69, p = .49; Cocaine: t36 = 0.61, p = .55. Similar magnitude λ scores as the within-
subjects data were also observed when using WTA and WTP values from this first task 
only subset (λ: Headphones = 0.83; Mug = 1.20; Cocaine = 1.17). 
Mixed Gambles Task Performance 
Means and standard deviations for λ on the mixed gambles task as well as gain and 
loss coefficients are presented in Table 3.2. Participants were, on average, equally 
sensitive to the magnitude of loss and gain as reflected by mean λ values of 
approximately 1 (Money Task = 0.99; Cocaine Task = 1.08). One-sample t-tests 
supported this conclusion by indicating a statistically significant difference from a λ of 2 
for money, t32 = 8.82, p < .001, d = 1.53, and cocaine, t30 = 8.63, p < .001, d = 1.55. 
Excluded participants reported more frequent cocaine use (22 versus 14 average 
days per month, t36 = 2.38, p = .02) and higher nicotine dependence scores (5.3 versus 
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3.4 average FTND, t36 = 2.47, p = .02), but did not differ on other demographic and drug 
use variables. Additionally, included and excluded participants did not differ on loss 
aversion values generated from the valuation tasks, Headphones: t36 = 0.29, p = .77; 
Mug: t36 = 0.42, p = .68; Cocaine: t36 = 0.09, p = .93. 
A secondary analysis of mixed gambles data indicated that the average predicted 
probability of gamble acceptance at an expected value of zero was 38.9% for cocaine 
and 30.8% for money. The expected value at which the predicted probability of gamble 
acceptance was 50% for the monetary and cocaine mixed gambles task was, on 
average, $3.5 and 0.0 grams cocaine, respectively. 
Loss Aversion by Risk and Commodity Condition 
Figure 3.1 displays λ values as a function of risk and commodity type. All 95% 
confidence intervals did not overlap with the normative value of 2 and indicated estimate 
precision as evidenced by tight interval width. A 2 x 2 ANOVA did not reveal a 
statistically significant main effect of Risk, F1,28 = 1.66, p = .21, ηp2 = .06, main effect of 
Commodity, F1,28 = 0.05, p = .83, ηp2 < .01, or Risk x Commodity interaction, F1,28 = 0.64, 
p = .43, ηp2 = .02. Counterbalance order and risk aversion did not impact these 
relationships as indicated by the lack of statistically significant main effects or 
interactions when included in the model. Similar results were observed when using linear 
mixed-effects models, with no statistically significant effects of Risk, p = .29, Commodity, 
p = .95, or Risk x Commodity interaction, p = .63. Loss aversion coefficients were also 
not significantly correlated with risk aversion, Mug Valuation: rsp < .01, p = .98; Cocaine 
Valuation: rsp = .14, p = .41; Traditional Gambles: rsp = .08, p = .65; Cocaine Gambles: rsp 
= .19, p = .28. 
Figure 3.2 contains individual participant data from the valuation task (circles) and 
mixed gambles task (squares). Individual data matched the group-averaged analyses 
well. Tight clustering was observed around mean values with few values deviating from 
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this central tendency (SDs: Non-Drug Valuation = 0.75; Drug Valuation = 0.58; Non-Drug 
Mixed Gambles = 0.66; Drug Mixed Gambles = 0.59). Furthermore, few participants 
exhibited loss aversion scores greater than 2 (~2-3 participants per task). 
Spearman correlations among loss aversion coefficients revealed two statistically 
significant associations. Higher loss aversion values on the mug valuation task were 
associated with higher values on the cocaine valuation task, r = .33, p = .04. In contrast, 
lower loss aversion values on the cocaine valuation task were associated with higher 
loss aversion on the monetary mixed gambles task, r = -.43, p = .01. All other 
associations were not statistically significant, Mug-Monetary Gambles: r = .08; Mug-
Cocaine Gambles: r = .04; Cocaine Valuation-Cocaine Gambles: r = .16; Monetary 
Gambles-Cocaine Gambles; r = .31. 
Individual Differences in Loss Aversion 
Table 3.3 contains associations between loss aversion outcomes and demographic 
and drug use variables. Mixed gambles λ values for both commodities were associated 
with self-reported days of past month cocaine use. Monetary gambles λ values were 
negatively associated with past month cocaine use. In contrast, cocaine gambles λ 
values were positively associated with past month cocaine use. Mug valuation λ values 
were also positively associated with self-reported alcoholic drinks per week. No other 
correlations between loss aversion and demographic and drug use variables were 
statistically significant. 
Cocaine Purchase Task 
One participant’s data were non-systematic and removed from data analysis due to 
poor demand fit (R2 = .25). Figure 3.3 shows the exponentiated model fit to mean 
cocaine demand (left) as well as the mean expenditure at each price (right). This model 
provided an excellent fit to mean consumption data (R2 = .99) as well as individual 
consumption data (Mean R2 = .93; SD = .05). Fits from the exponentiated model were 
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superior to the exponential model (Mean R2 = .79; SD = .09) and this difference was 
statistically significant, t35 = 9.99, p < .001, dz = 1.66. The correlation between derived 
(i.e., Q0) and reported intensity of demand (i.e., consumption at free price) was also 
stronger for the exponentiated model, r = .89, than exponential model, r = .81, although 
both associations were statistically significant. 
Table 3.4 contains means and standard deviations for cocaine purchase task 
outcomes and Table 3.5 contains associations between demand outcomes and loss 
aversion values. Cocaine λ values on the mixed gambles task were positively related to 
demand intensity and negatively related to demand elasticity. Cocaine λ values on the 
valuation task were positively related to breakpoint. Demand metrics were not 
significantly related to non-drug valuation or monetary mixed gambles outcomes. 
Table 3.6 contains correlations between these demand parameters and demographic 
and drug use variables. Derived and graphical demand intensity were positively related 
to days of cocaine use and money spent on cocaine per month as well as DAST scores. 
Omax and Pmax scores were also positively related to cigarette use variables. No other 
correlations were statistically significant.  
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Table 3.1 Loss Aversion Scores for Valuation Tasks 
     
  
Commodity 
WTA WTP Lambda (λ)     
Mean SD Mean SD Mean SD t d 
Headphones $7.05 $2.68 $7.55 $2.66 1.04* 0.50 11.83 1.92 
Mug $3.14 $1.74 $3.14 $1.81 1.15* 0.75 6.95 1.13 
Cocaine $75.26 $33.67 $70.00 $24.82 1.14* 0.58 9.10 1.48 
 
Note. WTA = Willingness-to-Accept; WTP = Willingness-to-Purchase. * p < .001 comparing 
λ to a value of 2. 
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Table 3.2 Loss Aversion Scores for Mixed Gambles Tasks 
 
Commodity 
Loss Coefficient Gain Coefficient Lambda (λ) 
Mean SD Mean SD Mean SD 
Money -0.43 0.24 0.53 0.29 0.99* 0.66 
Cocaine -0.49 0.32 0.48 0.28 1.08* 0.59 
 
Note. * p < .001 comparing λ to a value of 2. 
 
 
 
 
 
 
 
 
 
 Table 3.3 Semi-Partial Correlations Between Loss Aversion, Demographics, and Drug Use 
 
      Cigarette Use Alcohol Use Cocaine Use 
 
Age Male ZKPQ Income DAST CPD FTND 
Drinks/ 
Week MAST 
Days/ 
Month 
Money/ 
Month 
Riskless 
  
  
       
Mug- λ .18 -.18 .15 .15 -.13 -.01 -.10 .41* -.10 .14 -.05 
Cocaine- λ .04 .15 .02 -.11 .12 -.26 -.28 .04 .07 .18 .14 
Risky 
  
  
       
Money- λ -.01 .31 -.07 -.26 -.13 -.31 -.19 .01 .16 -.38* -.07 
Cocaine- λ -.01 -.15 .11 -.20 .13 -.20 .01 .03 -.04 .41* .11 
 
Note. WTA = Willingness-to-Accept; WTP = Willingness-to-Purchase; Income = Yearly Income; ZKPQ = Impulsivity 
Subscale of the Zuckerman-Kuhlman Personality Questionnaire; DAST = Drug Abuse Screening Test; CPD = 
cigarettes per day; FTND = Fagerström Test for Nicotine Dependence; MAST = Michigan Alcohol Screening Test. 
Semi-partial correlations controlled for gain and loss constituents of the λ ratio. Bold = statistically significant 
correlation. 
*p < .05; **p < .01 
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Table 3.4 Primary Outcomes on the Cocaine Purchase Task 
 
Outcome Mean SD 
Intensity 50.1 57.9 
Omax $516.4 $900.2 
Pmax $54.4 $165.5 
Breakpoint $156.9 $273.2 
Elasticity .0036 .0089 
Q0 47.2 58.9 
R2 .93 .05 
 
Note. Elasticity and Q0 fit using the 
exponentiated demand model. 
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Table 3.5 Semi-Partial Correlations Between Cocaine Demand and Loss Aversion 
Outcomes 
 
 
Intensity Omax Pmax Breakpoint Elasticity Q0 
Riskless 
     
 
Mug-λ <.01 -.20 -.24 -.14 .01 -.07 
Cocaine-λ .19 .25 .30 .36* -.20 -.05 
Risky 
     
 
Money-λ .08 -.20 -.18 -.18 .28 .14 
Cocaine-λ .42* .28 -.03 .19 -.45* .38* 
 
Note. Semi-partial correlations controlled for gain and loss constituents of the λ 
ratio. All demand metrics were log-transformed prior to analysis. Bold = 
statistically significant correlation. 
*p < .05; **p < .01 
 
  
Table 3.6 Spearman Correlations Between Demand Outcomes, Demographics, and Drug Use 
 
   
  
 Cigarette Use Alcohol Use Cocaine Use 
 
Age Male Income ZKPQ DAST CPD FTND 
Drinks/ 
Week MAST 
Days/ 
Month 
Money/ 
Month 
Intensity .04 .20 -.11 .08 .43** .26 .09 .09 -.05 .48** .63** 
Omax .17 .13 .03 .30 .05 .35* .31 .01 .02 .24 .31 
Pmax .27 -.11 .19 .22 -.13 .17 .35* -.15 -.05 -.15 -.01 
Breakpoint .22 .07 .29 .26 -.05 .30 .25 -.13 -.02 -.03 .16 
Elasticity .06 -.17 .01 -.17 .05 -.16 -.04 -.16 .06 -.22 -.20 
Q0 .11 .14 -.21 -.09 .37* .16 .08 .17 -.02 .44** .51** 
 
Note. Income = Yearly Income; CPD = cigarettes per day; ZKPQ = Impulsivity Subscale of the Zuckerman-Kuhlman 
Personality Questionnaire; DAST = Drug Abuse Screening Test; FTND = Fagerström Test for Nicotine Dependence; 
MAST = Michigan Alcohol Screening Test. All demand metrics were log-transformed prior to analysis. Bold = 
statistically significant correlation. 
*p < .05; **p < .01 
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Figure 3.1 Loss aversion coefficients for valuation (black bars) and mixed gambles 
(white bars) tasks. Data represented from all included participants on each task (n = 31 
to 38). Bars represent mean values and error bars represent 95% confidence intervals. 
Dotted line is placed at the normative loss aversion value of 2. 
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Figure 3.2 Individual participant data from valuation (circles) and mixed gambles 
(squares) tasks. Data represented from all included participants on each task (n = 31 to 
38). Means represented by solid horizontal lines in each column of data. Dotted line is 
placed at the normative loss aversion value of 2. 
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Figure 3.3 Economic demand for cocaine in active cocaine users (n = 37). Participants 
completed a cocaine purchase task in which hypothetical cocaine (0.1 g) was available. 
Price varied in United States dollars (USD) and hypothetical consumption measured. On 
the left is reported consumption plotted as mean (SD) group data on a log-linear axis fit 
using the exponentiated model (Equation 1 shown in the Methods). On the right is 
reported expenditure plotted as mean (SD) group data. 
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Chapter 4: Discussion 
The purpose of the present study was to evaluate loss aversion in active cocaine 
users. Cocaine users showed a robust and reliable reduction in loss aversion when 
compared to standard values obtained in the general population. This difference was 
observed across multiple tasks designed to evaluate loss aversion under conditions of 
certainty and conditions of risk. Attenuated loss aversion was also consistent across 
commodities, including non-drug (e.g., money) and hypothetical drug (e.g., cocaine) 
commodities. Hypothetical demand for cocaine decreased with increases in price and 
this relationship was well explained by mathematical models of demand. More intense 
and inelastic cocaine demand was associated with greater loss aversion for cocaine. 
These data represent the first comprehensive study on multiple dimensions of loss 
aversion in a substance using population and suggest that reductions in loss aversion 
are associated with a history of cocaine use. 
Participants reported similar sensitivities to gains and losses across conditions of 
certainty and risk as well as for drug and non-drug commodities. This absence of loss 
aversion, as indicated by λ values of 1, was remarkably consistent across all 
experimental conditions. These results are even more striking considering that 
inspection of individual data revealed few exceptions to this trend. Equally important to 
note is that the absence of loss aversion could not be attributed to the study’s within-
subjects design. A between-subject analysis using only data from the first task 
completed did not reveal statistically significant differences in the prices for selling and 
buying conditions. This analysis also indicated λ values similar to the within-subject 
comparison. This consistency is important because between-subjects manipulations 
analogous to this between-subject analysis are traditionally used to generate WTP, 
WTA, and λ values with valuation tasks (e.g., Kahneman et al., 1990; Novemsky & 
Kahneman, 2005). 
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A uniform response to gains and losses stands in direct contrast to the rich 
behavioral economic literature demonstrating that losses generally have a greater 
impact on behavior than gains (Kahneman & Tversky, 1979; Morewedge & Giblin, 2015; 
Tversky & Kahneman, 1991, 1992). The established 2:1 sensitivity of losses to gains (λ 
= 2) has been observed across a variety of experimental conditions, including the 
valuation and mixed gambles tasks used here (e.g., Gachter et al., 2007; Kahneman et 
al., 1990; Tom et al., 2007). Although controls were not explicitly recruited in the current 
study, comparison of the observed λ values to this normative and accepted value of 2 in 
the general population revealed statistically significant differences that were large in 
effect size. The robust nature of this difference combined with the consistency across 
and within experimental conditions provides convincing evidence for an attenuation of 
loss aversion in this cocaine-using population. 
Reliable correlations among measures of loss aversion were not observed. In fact, 
loss aversion for cocaine on the valuation task was negatively correlated with loss 
aversion for money on the mixed gambles task. Analysis of individual data revealed a 
high degree of homogeneity and clustering for λ values on each loss aversion task. It is 
possible that a low degree of variability resulted in range restriction and attenuation for 
the observed associations. Follow up studies could address this concern by recruiting 
individuals with more varied drug use and explore the relationship between loss aversion 
and different translational stages of cocaine misuse (e.g., recreational use, dysregulated 
use, abstinence, relapse, and recovery) or by studying individuals who report use of 
other drugs (e.g., opioids or cannabis). 
Economic demand for cocaine was effectively and efficiently measured using a 
hypothetical cocaine purchase task. Demand for cocaine systematically decreased with 
increases in price and was well explained by the exponentiated demand equation for a 
majority of participants (97.4%). The exponentiated model has recently been introduced 
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as an alternative to the typically used exponential model because it can incorporate the 
zero consumption values commonly observed with human purchase task data (whereas 
the exponential model cannot; Koffarnus et al., 2015; Strickland et al., in press). The 
current experiment provides additional support for the utility of the exponentiated model 
by demonstrating superior demand fit and association between self-reported and model-
derived measures of demand intensity. Cocaine demand parameters were also 
associated with measures of cocaine use (e.g., days used cocaine per month), 
consistent with other studies using alcohol and cigarette purchase tasks. These findings 
lend additional support for the construct validity of purchase task techniques for 
measuring cocaine use. Future research will be needed to evaluate the predictive 
validity of this measure for evaluating behavioral and pharmacological interventions for 
cocaine use disorder. 
More inelastic and intense cocaine demand was associated with greater loss 
aversion for cocaine on the mixed gambles task. Higher breakpoints were also 
associated with greater loss aversion on the cocaine valuation task. Relatedly, more 
frequent cocaine use was associated with higher loss aversion for cocaine and lower 
loss aversion for money on the mixed gambles tasks. These results collectively indicate 
that problematic cocaine use is positively associated with loss aversion for drug and 
negatively associated with loss aversion for non-drug commodities. This finding is 
consistent with the idea that problematic and prolonged substance use involves an 
increased focus on drug consumption coupled with a decreased attention to the negative 
consequences caused by that use (i.e., the loss of non-drug commodities; American 
Psychiatric Association, 2013). Future studies will be needed to further evaluate the 
association between drug demand, loss aversion, and traditional measures of drug-
taking behavior to replicate and clarify these relationships. 
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The current findings are congruent with the results of prior studies on loss aversion 
conducted in illicit drug users (e.g., Ahn et al., 2014; Fridberg et al., 2010; Vassileva et 
al., 2013). These studies have generally reported outcomes consistent with decreases in 
loss aversion by using computational modeling combined with IGT data. In one such 
study, chronic cannabis users showed attenuated loss aversion on the IGT relative to 
matched controls (Fridberg et al., 2010). Similar outcomes were reported in a later study 
with heroin-dependent patients in extended abstinence (> 3 months; Ahn et al., 2014). 
Most studies in cocaine users also report findings suggestive of decreases in loss 
aversion that are consistent with the present finding (Stout et al., 2004; Vassileva et al., 
2013). For example, drug use in a sample of HIV-positive women (that included a subset 
of individuals reporting cocaine use) was associated with diminished loss aversion on 
the IGT (Vassileva et al., 2013). It is important to note that the above findings were 
collected with an indirect measure of loss aversion (i.e., computational modeling of IGT 
performance) that is not traditionally used in behavioral economic research. This 
discrepancy makes comparisons to the broader behavioral economic literature difficult. A 
study presented at the 2014 annual meeting of the College on Problems of Drug 
Dependence reported enhanced loss aversion in HIV-positive cocaine users on a task 
similar to the mixed gambles task used here (Meade et al., 2014). The reasons for the 
discordance between these findings and the present study are not known; however, it is 
possible that HIV comorbidity in this other sample influenced the experimental 
outcomes. It is also important to recognize that these findings have not been published 
in a peer-reviewed format and only represent a preliminary data analysis. Thus, the 
results from the majority of previous research in substance using populations coupled 
with the present findings suggest that drug use is associated with the decreased and 
possible absence of loss aversion.  
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A review of laboratory studies conducted in other clinical populations offers several 
behavioral and neurobiological mechanisms that may underlie the absence of loss 
aversion observed in cocaine users. Problem gamblers, for example, have generally 
shown similar decreases in loss aversion (Brevers et al., 2012; Lorains et al., 2014; but 
see Giorgetta et al., 2014). These decreases have been reported in non-treatment 
seeking gamblers (Brevers et al., 2012) as well as those in outpatient treatment (Lorains 
et al., 2014). High rates of comorbidity are observed between problem gambling and 
substance use, with some suggesting that dysregulation in impulsive behavior is the 
common trait underlying these disorders (Lorains, Cowlishaw, & Thomas, 2011; Peters 
et al., 2015; Verdejo-Garcia, Lawrence, & Clark, 2008). It is possible that changes in 
impulsive behavior also represent the behavioral mechanism underlying the decreased 
loss aversion observed in these populations. Although the relationship between 
impulsive behavior and loss aversion has not been extensively examined, preliminary 
evidence obtained in adolescents suggests that higher rates of impulsivity are 
associated with decreases in loss aversion (Ernst et al., 2014). A correlation between 
loss aversion and the impulsivity subscale of the ZKPQ was not observed in this study. 
Self-report measures like the ZKPQ likely reflect broader indicators of trait personality 
rather than specific and individual types of impulsive behavior (de Wit, 2009; Reynolds, 
Ortengren, Richards, & de Wit, 2006). These measures also require the participant to 
accurately assess behavior over a variety of situations and typically only show modest 
correlation with more direct behavioral measures (Cyders & Coskunpinar, 2011; de Wit, 
2009; Reynolds et al., 2006). The use of methods that examine specific behavioral 
constructs of impulsive behavior (e.g., delay discounting; response inhibition) in future 
studies will be important for evaluating the functional relationship between impulsivity 
and loss aversion.  
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Reductions in loss aversion are also consistently observed in individuals with 
schizophrenia (Brown et al., 2013; Kim, Kang, & Lim, 2016; Tremeau et al., 2008). For 
example, patients with schizophrenia have failed to show loss aversion in a valuation 
task similar to the one used here (λ = 0.87; Tremeau et al., 2008). Individuals with 
schizophrenia also show impaired assessment of expected value on a mixed gambles 
task (Brown et al. 2013). Dopaminergic theories of schizophrenia posit that dysfunction 
in presynaptic dopaminergic terminals contributes to the development and persistence of 
the disorder (see review by Howes, McCutcheon, & Stone, 2015). Chronic cocaine use 
also results in functional alterations in the dopaminergic system, including 
downregulation of dopamine D2 receptors and a hypo-dopaminergic state (Goldstein et 
al., 2010; Volkow et al., 1996). Disrupted and aberrant signaling in the dopamine system 
could represent a neurobiological mechanism mediating decreased loss aversion. In 
fact, neuroimaging research suggests that regions in the mesolimbic dopamine system 
play a role in loss aversion (Tom et al., 2007). Participants in that study completed a 
mixed gambles task while fMRI techniques were used to evaluate the neural systems 
activated during gains and losses. It was found that loss anticipation produced 
deactivation in mescorticolimibic structures and that this diminished neural sensitivity 
was associated with decreased loss aversion. Recent evidence that links functional 
polymorphisms in BDNF and ANKK1 genes to changes in loss aversion also supports 
this dopamine hypothesis (Voigt, Montag, Markett, & Reuter, 2015). Specifically, 
participants in that study with polymorphisms related to decreased BDNF secretion and 
D2 receptor density and binding reported the lowest loss aversion scores. Follow-up 
studies are needed to test this dopamine hypothesis because similar behavioral 
phenotypes (e.g., reduced loss aversion) may arise from distinct neurobiological 
mechanisms. Pharmacological manipulations directly targeting the dopaminergic system 
(e.g., acute amphetamine and/or haloperidol challenge) and additional neuroimaging 
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studies evaluating both structure and function in combination with behavior could help 
elucidate the role of dopamine in mediating the expression of loss aversion.  
Loss aversion has also been implicated in limbic system function and, in particular, 
amygdala activity. For example, damage to the amygdala abolishes behavioral 
expression of loss aversion under risky conditions (De Martino et al., 2010). In that 
study, two patients with focal bilateral amygdala lesions completed a mixed gambles 
task and performance compared to matched controls. Dramatic attenuation of loss 
aversion was observed in these patients despite no differences in risk aversion or 
expected value computation (i.e., preference for larger gains and smaller losses). Loss 
aversion on mixed gambles tasks is also associated with differential amygdala activity 
following losses and gains in healthy participants (Sokol-Hessner, Camerer, & Phelps, 
2013). Participants in that study were healthy, college students who completed a mixed 
gambles task combined with fMRI. Greater BOLD activity in the amygdala in response to 
losses relative to gains was associated with greater expression of loss aversion (i.e., 
higher λ values). 
These findings suggest a potential arousal mechanism involved in loss aversion 
given the role that the amygdala and the greater limbic structures play in regulating 
arousal and emotion. Support for this hypothesis comes from skin conductance studies 
that have demonstrated greater autonomic response to losses than gains and that these 
differences are positively associated with loss aversion (i.e., greater autonomic response 
to loss than gain is correlated with greater loss aversion; Sokol-Hessner et al., 2009; 
Wu, Van Dijk, Aitken, & Clark, 2016). An autonomic arousal mechanism is also 
supported by a recent study in which administration of the β-adrenergic receptor 
antagonist propranolol reduced loss aversion, but had no effect on risk sensitivity or 
choice consistency (Sokol-Hessner et al., 2015). Awareness of one’s arousal also likely 
contributes to loss aversion because interoception (i.e., sensitivity to internal 
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physiological states) positively correlates with loss aversion (Sokol-Hessner, Hartley, 
Hamilton, & Phelps, 2015). In that study, performance on a heartbeat-detection task 
used to measure interoceptive ability was positively correlated with loss aversion on a 
mixed gambles task. Interoceptive performance was not associated with risk response or 
choice consistency indicating that the relationship was specific to loss aversion. 
The association between interoception, limbic system function, and loss aversion is 
notable given recent arguments that addictive behaviors are functionally tied to 
dysregulated interoceptive activity, deficits in arousal, and disrupted activity in the insular 
cortex (see reviews by Paulus & Stewart, 2014; Paulus, Tapert, & Schulteis, 2009). 
Cocaine use is related to changes in amygdala structure and function, including 
decreases in overall volume and binding potential (e.g., Makris et al., 2004; Milella et al., 
2014). More broadly, cocaine use is associated with decreases in mesocorticolimbic 
system volume and reduced functional connectivity among system circuits (e.g., Gu et 
al., 2010; Hu, Salmeron, Gu, Stein, & Yang, 2015; Rando, Tuit, Hannestad, Guarnaccia, 
& Sinha, 2013). Few studies have systematically examined interoception in cocaine 
users, but some data exists suggesting compromised interoceptive awareness and 
alterations in the structure and function of the insular cortex (e.g., Cisler et al., 2013; 
Ersche et al., 2014; Stewart, Juavinett, May, Davenport, & Paulus, 2015). More work is 
needed, however, to understand possible changes in interoceptive awareness among 
cocaine users and how these changes might relate to loss aversion. 
Several limitations of the current study should be noted. First, these data represent a 
cross-sectional analysis of loss aversion in current cocaine users. Longitudinal studies 
are necessary for differentiating those effects that are antecedent to and those that are a 
consequence of cocaine use. Such findings will help determine if loss aversion 
represents a predisposing/risk factor for developing a cocaine use disorder or is a result 
of a history of cocaine use (or, most likely, a combination of the two). Such a distinction 
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is crucial for determining to what extent loss aversion may provide a behavioral marker 
for substance use diagnosis and assessment. 
Second, comparisons between the monetary and cocaine mixed gambles tasks 
should be made with caution because the ranges of gains and losses, outcomes of 
decisions (i.e., real versus hypothetical), and qualitative nature of the commodities (i.e., 
dollars versus grams) were different. Of particular note, a recent study found that the 
gain and loss ranges used on mixed gambles tasks can influence the derived loss 
aversion coefficient (Walasek & Stewart, 2015). Participants in that study were randomly 
assigned to complete mixed gambles tasks with varying distributions of gains and 
losses. Discrepant loss aversion outcomes were observed with each of these range 
conditions, including the expression of loss aversion, absences of loss aversion, and 
reverse of loss aversion (λ < 1). The gain and loss ranges used in the present study 
were identical to a range that produced loss aversion in the aforementioned study (λ = 
1.93; Walasek & Stewart, 2015) as well as other demonstrations of loss aversion in 
healthy participants (λ = 1.93; Tom et al., 2007). Thus, it is unlikely that the lower loss 
aversion observed on the mixed gambles task was due to this methodological variable. 
Third, it is unclear how loss aversion might relate to other behavioral mechanisms 
implicated in substance use disorders. The current study evaluated economic demand 
for cocaine, but did not include other common principles studied in the behavioral 
economic and substance use literatures (e.g., delay discounting, status quo bias; 
Chivers & Higgins, 2012). As noted above, a rich body of literature has demonstrated the 
relationship between drug use and delay discounting (Bickel  et al., 2012). It is possible 
that loss aversion and delay discounting represent related behavioral phenomenon that 
are similarly related to substance use disorders. However, it is also possible that these 
principles represent non-overlapping constructs that uniquely predict drug use. Future 
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research could include additional behavioral economic measures in order test such 
predictions. 
Fourth, a substantial proportion of data were excluded from the mixed gambles task 
due to the inability to effectively generate loss aversion coefficients. Model convergence 
was not possible or stable in many of these cases due to the high proportion of gambles 
accepted by some participants (e.g., acceptance of all or nearly all gambles). High rates 
of gamble acceptance could be indicative of confusion about the task and its outcomes. 
Alternatively, these data could indicate extreme loss aversion (or lack thereof) in which 
any loss, no matter how large or small, is ineffective at changing behavior. Supporting 
this hypothesis, excluded participants reported higher rates of cocaine use and greater 
nicotine dependence. Additional comparisons made using linear mixed-effects models 
that allowed for inclusion of participants with missing data did not result in qualitatively 
different outcomes. Analysis of data from the valuation tasks also indicated that these 
excluded participants did not differ on WTA, WTP, or λ values meaning that their 
exclusion from some analyses was unlikely to have systematically biased study 
outcomes.  
Finally, it is possible that changes in loss aversion are epiphenomenally related to 
other primary causal agent(s) implicated in substance use disorders. For example, 
socioeconomic status (SES) is frequently tied to drug use and other adverse health 
behaviors (Galea & Vlahov, 2002; Gilman, Abrams, & Buka, 2003). Although few studies 
have systematically studied the relationship between loss aversion and SES, the existing 
literature suggests that lower SES is correlated with lower loss aversion (Gachter et al., 
2007). Participants in the present sample reported a mean yearly income that was below 
the poverty threshold (Mean = $7155/year), however, income was not related to the 
magnitude of loss aversion. It is possible that differences in SES between populations 
rather than within this population might explain the lower loss aversion observed relative 
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to individuals typically sampled in loss aversion studies (e.g., undergraduate and 
graduate-level college students). Future studies will be needed to evaluate SES and 
other alternative explanations for the relationship between loss aversion and substance 
use. 
Loss aversion could provide important translational implications for treatment and 
interventions development. If loss aversion represents a behavioral mechanism 
underlying the disadvantageous choices characteristic of substance use disorders, then 
altering this bias could result in reciprocal changes in drug-taking behavior. This 
possibility is not unwarranted given that loss aversion is sensitive to cognitive-regulation 
strategies (Sokol-Hessner et al., 2009). For example, participants who engage in a 
regulation strategy that emphasizes choices in isolation show greater loss aversion than 
those engaged in a strategy that emphasizes choices in a broader setting (Sokol-
Hessner et al., 2009). Incorporating cognitive strategies designed to change loss 
aversion in the context of other interventions, such as cognitive-behavioral therapy, 
might provide an efficient means to modify drug-taking behavior.  
Loss aversion is also closely tied to CM and the framing of incentives as gains or 
losses. Reinforcers delivered in CM may be framed as either a gain contingent on the 
presence of a desired behavior (e.g., positive reinforcement) or as a loss due to the 
absence of a desired behavior (e.g., negative reinforcement; contract based 
approaches). The present findings suggest a uniform sensitivity to loss and gain that 
may make both forms of incentive framing in CM equally effective. Additional tests are 
needed to determine if loss aversion may provide a putative moderator of CM efficacy 
and allow for patient-level tailoring of CM designs. 
Prospect theory and loss aversion were first introduced to explain deviations from 
traditional economic theory and the idea that a rational decision maker makes decisions 
based on expected utility. Participants in the present study unexpectedly operated under 
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conditions more closely aligned with an expected utility hypothesis than the “irrational” 
agent described by prospect theory. The reported loss aversion values (i.e., ) of one 
suggest an equal sensitivity to losses and gains (i.e., loss equivalence) that is predicted 
by an expected utility model of choice. For example, decisions in the mixed gambles 
task approximated decision-making based on expected utility (e.g., indifference at an 
expected value of zero). That cocaine users displayed rational economic choice is 
consistent with the growing body of literature challenging the assumption that individuals 
with substance use disorders exhibit extensive cognitive impairment and uncontrollable, 
irrational behavior (e.g., Hart, Marvin, Silver, & Smith, 2012). Decisions based on 
expected utility and made with a proportional weight given to gains and losses are often 
desirable and advantageous (e.g., in market trading, investing, gambling). However, loss 
equivalence may also decrease the appropriate attention needed to harmful 
consequences that loss aversion may otherwise protect against (e.g., the decision to use 
drugs despite the negative health, social, and/or economic consequences). It is possible 
that this inattention contributes to the impaired insight into drug use and need for 
treatment that often impede intervention efforts in substance-using populations. 
Addressing loss aversion in this respect may help improve awareness and evaluation of 
the negative consequences of drug use to encourage treatment-seeking behavior and 
improve retention in existing interventions. 
The current findings expand the extant literature on the intersection of behavioral 
economics and addiction science by using multi-method, within-subjects techniques to 
study loss aversion in cocaine users. There have been no studies conducted using the 
valuation task in substance-using populations. Similarly, no studies have used the 
ecological relevant commodity of abused drugs when examining loss aversion. Reliable 
and robust evidence for decreased loss aversion in cocaine users was observed and 
several behavioral and neurobiological mechanisms consistent with these results were 
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identified. Research examining these putative mechanisms and the functional 
relationship between loss aversion and drug-taking behavior will be crucial for the future 
of loss aversion in directing treatment and interventions development efforts. 
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housed rats. Behavioural Pharmacology, 24, 114-123 
 
Encyclopedia Entries and Book Reviews 
1. Strickland JC (in press) Nonparametric statistics. The SAGE Encyclopedia of 
Industrial and Organizational Psychology, 2nd edition 
2. Strickland JC (2014) Textbook review: Guide to research techniques in 
neuroscience. The Journal of Undergraduate Neuroscience Education, 13, R1-R2 
 
Posters and Presentations 
Oral Presentations 
1. Strickland JC* (2016) Emerging reforms in psychological science:  How the 
changing face of scientific research may Influence your research. Symposium at the 
124th annual meeting of the American Psychological Association: Denver, CO 
*Symposium Chair 
2. Strickland JC, Rush CR, and Stoops WW (2016) Influence of cocaine cues on 
monetary choice in cocaine users. Oral presentation at the 78th annual meeting of 
the College on Problems of Drug Dependence: Palm Springs, CA 
3. Strickland JC (2016) Using Amazon’s Mechanical Turk (mTurk) to sample 
substance using populations. Invited workshop presentation at the 78th annual 
meeting of the College on Problems of Drug Dependence: Palm Springs, CA 
4. Harvanko AM, Strickland JC, and Reynolds BA (2016) Predicting contingency 
management treatment efficacy by using measures of impulsivity. Oral presentation 
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at the 78th annual meeting of the College on Problems of Drug Dependence: Palm 
Springs, CA 
5. Robinson AM, Lacy RT, Strickland JC, Magee CP, and Smith MA (2016) The 
effects of social contact on “binge” cocaine self-administration. Oral presentation at 
the 78th annual meeting of the College on Problems of Drug Dependence: Palm 
Springs, CA 
6. Putka DJ, Strickland JC, and Tonidandel S (2016) Estimating relative weights in the 
face of model selection uncertainty. Oral presentation at the 31st annual conference 
of the Society for Industrial and Organizational Psychology: Anaheim, CA 
7. Strickland JC, Rush CR, and Stoops WW (2015) Contribution of conditioned drug 
action to cocaine self-administration. Oral presentation at the satellite meeting of the 
International Study Group Investigating Drugs as Reinforcers: Phoenix, AZ 
8. Smith MA, Strickland JC, Lacy RT, Witte MA, Abel JM, and Lynch WJ (2015) The 
effects of strength training on the positive reinforcing effects of cocaine. Oral 
presentation at the 59th annual meeting of the Behavioral Pharmacology Society: 
Boston, MA 
9. Lacy RT, Strickland JC, and Smith MA (2014) The effects of social learning on the 
acquisition of drug self-administration. Oral presentation at the satellite meeting of 
the International Study Group Investigating Drugs as Reinforcers: San Juan, Puerto 
Rico 
10. Strickland JC*, Pinheiro AP, Cecala KK, and Dorcas ME (2014) Physiological 
constraints to respond to climate change: Insights from the effects of temperature on 
standard metabolic rate in larval salamanders. Oral presentation at the 75th annual 
meeting of the Association of Southeastern Biologists: Spartanburg, SC 
*Awarded Student Research Award 
11. Strickland JC (2013) Effects of resistance exercise on the positive reinforcing 
effects of cocaine. Oral presentation at the 2013 Wake Forest-Emory Lab Exchange: 
Atlanta, GA 
12. Strickland JC, Nyein, KP, White TE, and Good JJ (2013) The effects of Good 
Samaritan law awareness on helping behavior. Oral presentation at the 38 th annual 
Carolina’s Psychology Conference: Raleigh, NC 
 
Poster Presentations 
1. Strickland JC and Stoops WW (2016) Latent factor structure of cocaine demand in 
an online sample of cocaine users. Poster presentation at the 124th annual meeting 
of the American Psychological Association: Denver, CO 
2. Wagner FP, Romanelli MR, Strickland JC, Lile JA, Stoops WW, and Rush CR 
(2016) Relationship between age of drug use initiation and self-reported ADHD 
symptoms in cocaine users. Poster presentation at the 124th annual meeting of the 
American Psychological Association: Denver, CO 
3. Strickland JC, Lile JA, Rush CR, and Stoops WW (2016). Sensitivity to 
reinforcement and punishment learning in active cocaine users. Poster presentation 
at the 8th annual Behavior, Biology, and Chemistry: Translational Research in 
Addiction Conference: San Antonio, TX 
4. Strickland JC and Stoops WW (2015) Perceptions of research risk and undue 
influence in an online sample of cocaine users. Poster presentation at the 16 th 
annual meeting of the European Behavioral Pharmacology Society: Verona, Italy 
5. Magee CP, Lacy RT, Robinson AM, Strickland JC, and Smith MA (2015) The 
effects of social contact on “binge” cocaine self-administration. Poster presentation at 
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the 23rd annual Faculty for Undergraduate Neuroscience Satellite Event at the 
Society for Neuroscience: Chicago, IL 
6. Strickland JC, Stoops WW, and Rush CR (2015) The association between 
intranasal methamphetamine self-administration and subject-rated effects. Poster 
presentation at the 123rd annual meeting of the American Psychological Association: 
Toronto, Canada 
7. Lacy RT, Strickland JC, Bills SE, and Smith MA (2015) A shared history of drug 
exposure influences social preference. Poster presentation at the 123rd annual 
meeting of the American Psychological Association: Toronto, Canada 
8. Strickland JC, Stoops WW, and Rush CR (2015) The relationship between 
methamphetamine self-administration and subject-rated effects. Poster presentation 
at the 77th annual meeting of the College on Problems of Drug Dependence: 
Phoenix, AZ 
9. Wagner F, Strickland JC, Stoops WW, and Rush CR (2015) Feasibility of web-
based treatment delivery for cocaine use disorder: Profile of Internet access by 
active cocaine users. Poster presentation at the 77th annual meeting of the College 
on Problems of Drug Dependence: Phoenix, AZ 
10. Lacy RT, Feinstein MA, Strickland JC, and Smith MA (2015) The effects of estrous 
cycling on cocaine self-administration in socially housed male-female dyads. Poster 
presentation at the 77th annual meeting of the College on Problems of Drug 
Dependence: Phoenix, AZ 
11. Strickland JC*, Rush CR, and Stoops WW (2015) Discriminative-stimulus effects of 
tramadol: An individual subjects analysis of mu opioid-receptor mediated effects. 
Poster presentation at the 7th annual Behavior, Biology, and Chemistry: Translational 
Research in Addiction Conference: San Antonio, TX 
*Awarded Outstanding Poster Presentation 
12. Strickland JC, Lacy RT, Brophy MK, Witte MA, and Smith MA (2014) Aerobic 
exercise decreases speedball self-administration in female rats.  Poster presentation 
at the 76th annual meeting of the College on Problems of Drug Dependence: San 
Juan, Puerto Rico 
13. Smith MA, Lacy RT, and Strickland JC (2014) The effects of social learning on the 
acquisition of cocaine self-administration. Poster presentation at the 76th annual 
meeting of the College on Problems of Drug Dependence in San Juan, Puerto Rico 
14. Bahram CH, Strickland JC, Harden LA, Pittman SE, Kern MM, and Dorcas ME 
(2014) Influence of sex and migration behavior on reproductive cost of spotted 
salamander. (Ambystoma maculatum). Poster presentation at the 75th annual 
meeting of the Association of Southeastern Biologists: Spartanburg, SC 
15. Smith MA, Strickland JC, Pitts EG and Witte MA (2013) The effects of forced 
running procedures on the self-administration of cocaine. Poster presentation at the 
1st annual meeting of Collaborative Perspectives on Addiction: Atlanta, GA 
16. Smith MA, Strickland JC, and Witte MA (2013) The effects of strength training on 
cocaine self-administration. Poster presentation at the 75th annual meeting of the 
College on Problems of Drug Dependence: San Diego, CA 
17. Strickland JC, Witte MA, and Smith MA (2013) The effects of exercise on cocaine 
self-administration: Role of strength and resistance training. Poster presentation at 
the 7th annual Symposium for Young Neuroscientists and Professors of the 
SouthEast: Columbia, SC 
18. Strickland JC and Smith MA (2012) The effects of forced running procedures on the 
self-administration of cocaine. Poster presentation at the 20th annual Faculty for 
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Undergraduate Neuroscience Satellite Event at the Society for Neuroscience: New 
Orleans, LA 
19. Smith MA, Pietz GW, Strickland JC, Pitts EG, Tonidandel S, and Foley MC (2012)   
Peer influences on drug self-administration: An econometric analysis in socially 
housed rats. Poster presentation at the 42nd annual meeting of the Society for 
Neuroscience: New Orleans, LA 
20. Strickland JC, Pitts EG, and Smith MA (2012) The relationship between exercise 
duration and the positive reinforcing effects of cocaine. Poster presentation at the 6th 
annual Symposium for Young Neuroscientists and Professors of the SouthEast: 
Columbia, SC 
21. Strickland JC and Smith MA (2011) The effects of aerobic exercise on cocaine self-
administration: Importance of exercise output. Poster presentation at the 19th annual 
Faculty for Undergraduate Neuroscience Satellite Event at the Society for 
Neuroscience: Washington, DC 
 
PROFESSIONAL ACTIVITY AND SERVICE        
 
Scientific and Professional Society Service 
APA Science Student Council Chair 2016-Present 
APA Division 28 Graduate Student Representative  2015-Present 
APA Division 28 Undergraduate Scholarship Committee Chair 2015-Present 
APA Science Student Council Biopsychology Representative 2015-Present 
CPDD Travel Awards Committee Member   2015-Present 
International Study Group Investigating Drugs as Reinforcers Webmaster 2014-Present 
 
Department and University Activity and Service 
University of Kentucky 
 Area Brown Bag Coordinator 2016-Present 
 Psychology Department Event Planning Committee 2016-Present 
Davidson College 
Psi Chi President 2013-2014 
Honor Council Representative 2011-2014 
 
Scientific and Professional Society Membership 
American Psychological Association, Graduate Student Affiliate  2014-Present 
American Psychological Association Division 28, Student Member  2014-Present 
American Psychological Association Division 50, Student Member  2014-Present 
College on Problems of Drug Dependence, Student Member 2014-Present 
International Study Group Investigating Drugs as Reinforcers, Member 2014-Present 
Phi Beta Kappa Honor Society 2014-Present 
Psi Chi Psychology Honor Society 2012-Present 
 
Mentoring Activity 
Marisa Doll, University of Kentucky College of Arts and Science 2015-2016 
Michael Romanelli, University of Kentucky College of Medicine 2015-2016 
Meredith Doughty, University of Kentucky College of Agriculture 2015 
 
Teaching Activity 
Davidson College Teaching Assistant Biology 111-Molecules, Genes, and Cells 2014 
Davidson College Head Statistics Teaching Assistant 2012-2014 
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Ad Hoc Reviewer 
Addiction Biology; Biological Psychiatry; Drug and Alcohol Dependence; European 
Journal of Pharmacology; Experimental and Clinical Psychopharmacology; Journal of 
Addiction Medicine; Pharmacology, Biochemistry, and Behavior 
